Lineage Cell Therapeutics, Inc.
LCTXCIK 0000876343 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K filed Mar 5, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:Material rewriteFull-doc fallback
Full filing:tone -0.0153Δ+0.000483% similar+754/-538 ¶
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Lineage Cell Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Culley Brian M | OfficerDirector | 18 |
| Samuel George A. III | Officer | 12 |
| Bradsher Neal C | Director10% Owner | 6 |
| Howe Jill Ann | Officer | 6 |
| Mulroy Michael H. | Director | 5 |
Showing 1-5 of 15
Page 1 of 3Next
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Lineage Cell Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Culley Brian M | 4 | 50% | +0.1% | -2.1% | +20.0% | -15.2% |
| 2 | Bradsher Neal C | 10 | 40% | -3.1% | 0.0% | +17.1% | -25.8% |
| 3 | Broadwood Capital Inc | 10 | 40% | -3.1% | 0.0% | +17.1% | -25.8% |
| 4 | Broadwood Partners, L.P. | 10 | 40% | -3.1% | 0.0% | +17.1% | -25.8% |
All filings
71 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|